Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Kettering Health Network
64 participants
Feb 15, 2019
INTERVENTIONAL
Conditions
Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Eligibility
Inclusion Criteria2
- carpal tunnel syndrome diagnosed either by physical exam or EMG
- age >18.
Exclusion Criteria5
- allergy to bupivacaine
- pre-operative opioid usage within the last six months
- patients allergic to Percocet or acetaminophen
- patients taking tricyclic antidepressants (interaction with bupivacaine)
- vulnerable populations (prisoners or pregnant women)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The investigators aim to investigate an alternative (vs "standard") pain management strategy for post operative carpal tunnel release. All drugs used are FDA approved for these indications, and no drug itself is being investigated.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03867539